{"id":"https://openalex.org/W4231090214","doi":"https://doi.org/10.1158/1538-7445.am2019-3812","title":"Abstract 3812: Overcoming de novo and acquired modes of cetuximab resistance by broad-spectrum receptor tyrosine kinase inhibitors","display_name":"Abstract 3812: Overcoming de novo and acquired modes of cetuximab resistance by broad-spectrum receptor tyrosine kinase inhibitors","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4231090214","doi":"https://doi.org/10.1158/1538-7445.am2019-3812"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-3812","doi":"https://doi.org/10.1158/1538-7445.am2019-3812","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-3812","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090179644","display_name":"Bhuminder Singh","orcid":"https://orcid.org/0000-0003-1357-2158","observed_orcids":["https://orcid.org/0000-0003-1357-2158"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhuminder Singh","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036988988","display_name":"Ramona Graves\u2010Deal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramona Graves-Deal","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041399222","display_name":"Galina T. Bogatcheva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Galina Bogatcheva","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046249010","display_name":"Robert J. Coffey","orcid":"https://orcid.org/0000-0002-2180-3844","observed_orcids":["https://orcid.org/0000-0002-2180-3844"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Coffey","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I901861585"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"3812","last_page":"3812"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab-resistance","display_name":"cetuximab resistance","score":0.9739999771118164},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8809999823570251},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/bms-777607","display_name":"BMS-777607","score":0.9929999709129333},{"id":"https://openalex.org/keywords/met","display_name":"MET","score":0.5450000166893005},{"id":"https://openalex.org/keywords/ron","display_name":"RON","score":0.9819999933242798},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.5889999866485596},{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.890999972820282},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.6380000114440918},{"id":"https://openalex.org/keywords/de-novo-resistance","display_name":"de novo resistance","score":0.7940000295639038},{"id":"https://openalex.org/keywords/wnt-signaling","display_name":"Wnt signaling","score":0.6880000233650208},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.6790000200271606},{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":0.8579999804496765},{"id":"https://openalex.org/keywords/spindle-positioning","display_name":"spindle positioning","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9838491678237915},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.8686659336090088},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.7787922620773315},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6681365370750427},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5217338800430298},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.5057709217071533},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.43261411786079407},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3964635729789734},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3833576738834381},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37649935483932495},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36417537927627563},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35636574029922485},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.34203094244003296},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.27467918395996094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.250405877828598},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.13917776942253113},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.11733844876289368},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-3812","doi":"https://doi.org/10.1158/1538-7445.am2019-3812","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-3812","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2914971500","https://openalex.org/W3083434439","https://openalex.org/W3180589295","https://openalex.org/W4282982241","https://openalex.org/W4311092962","https://openalex.org/W4362595285","https://openalex.org/W2742019054","https://openalex.org/W4409628231","https://openalex.org/W2508206205","https://openalex.org/W4393072411"],"abstract_inverted_index":{"Abstract":[0],"MEK":[1],"inhibition":[2,290],"has":[3],"been":[4],"shown":[5],"to":[6,42,73,89,97,114,174,236],"delay":[7],"emergence":[8],"of":[9,63,87,109,161,198,204,222,238,298,307,343,355],"cetuximab":[10,64,80,90,141,151,187,211,260,269,308,344],"resistance":[11,41,81,96,152,212,270,345],"in":[12,51,53,92,104,131,153,168,213,250,253,271,273,279],"colorectal":[13],"cancer":[14],"(CRC)":[15],"(Nat":[16,118],"Commun":[17],"22;6:8305,":[18],"2015).":[19],"By":[20,44,241],"exploiting":[21],"a":[22,46,280,295],"novel":[23,61],"3D":[24,52,67,192],"culture":[25],"system,":[26],"we":[27,57,244,264,293],"herein":[28],"show":[29,145,265],"that":[30,94,112,135,146,266],"three":[31],"broad-spectrum":[32,347],"tyrosine":[33,129,349],"kinase":[34,350],"inhibitors":[35,181,351],"overcome":[36,186],"de":[37,78,338],"novo":[38,79,339],"and":[39,127,134,166,170,183,195,208,224,255,261,288,309,340],"acquired":[40,95,150,341],"cetuximab.":[43],"culturing":[45],"CRC":[47],"cell":[48,233,247],"line,":[49],"HCA-7":[50],"type":[54],"I":[55],"collagen,":[56],"previously":[58,123],"identified":[59],"two":[60],"modes":[62,342],"resistance.":[65,142],"In":[66],"culture,":[68],"HCA-7-derived":[69],"CC":[70,88,176,214,239],"are":[71],"sensitive":[72],"cetuximab,":[74,98],"while":[75],"SC":[76,132,140,169,254,274],"exhibit":[77],"(PNAS":[82],"114:E2852-E2861,":[83],"2017).":[84,121],"Continuous":[85],"exposure":[86],"resulted":[91],"colonies":[93],"designated":[99],"CC-CR,":[100],"which":[101,216],"was":[102,226,320],"dependent":[103],"part":[105],"on":[106],"increased":[107,115,125,159,246],"levels":[108],"lncRNA":[110],"MIR100HG":[111],"leads":[113],"WNT":[116],"signaling":[117,200],"Med":[119],"23:1331-1341,":[120],"We":[122,143],"showed":[124,158],"MET":[126,165],"RON":[128],"phosphorylation":[130,160],"cells":[133,172],"MET/RON":[136],"inhibitor,":[137],"crizotinib":[138,147,223,267,310],"overcomes":[139,149,268],"now":[144],"also":[148],"CC-CR.":[154],"A":[155],"phospho-RTK":[156],"array":[157],"several":[162],"RTKs,":[163],"including":[164],"RON,":[167],"CC-CR":[171,256],"compared":[173],"cetuximab-sensitive":[175],"counterparts.":[177],"Furthermore,":[178,263],"other":[179],"multi-RTK":[180],"cabozantinib":[182],"BMS-777607":[184],"helped":[185],"resistance,":[188],"as":[189],"measured":[190],"by":[191,220,346],"colony":[193],"growth":[194],"activation":[196],"state":[197],"key":[199],"molecules.":[201],"Conversely,":[202],"addition":[203,221],"RTK":[205],"ligands":[206],"HGF":[207],"NRG1":[209],"induced":[210],"cells,":[215],"could":[217],"be":[218],"blocked":[219],"this":[225],"associated":[227],"with":[228,259,300],"disorganized":[229],"spindle":[230],"positioning":[231],"during":[232],"division,":[234],"leading":[235],"multi-layering":[237],"cultures.":[240],"FACS":[242],"analysis,":[243],"observed":[245,294],"cycle":[248],"arrest":[249],"G1":[251],"phase":[252],"cultures":[257],"treated":[258],"crizotinib.":[262],"vivo":[272],"nude":[275],"mice":[276],"xenografts.":[277],"Finally,":[278],"direct":[281],"comparison":[282],"between":[283],"vertical":[284],"suppression":[285],"(EGFR/MEK":[286],"inhibition)":[287],"parallel":[289],"(EGFR/multi-RTK":[291],"inhibition),":[292],"higher":[296],"degree":[297],"synergy":[299],"the":[301,324,356],"latter":[302],"strategy.":[303],"The":[304],"non-overlapping":[305],"toxicities":[306],"warrants":[311],"consideration":[312],"for":[313,359],"its":[314],"clinical":[315],"deployment.":[316],"Note:":[317],"This":[318],"abstract":[319],"not":[321],"presented":[322],"at":[323],"meeting.":[325],"Citation":[326],"Format:":[327],"Bhuminder":[328],"Singh,":[329],"Ramona":[330],"Graves-Deal,":[331],"Galina":[332],"Bogatcheva,":[333],"Robert":[334],"J.":[335],"Coffey.":[336],"Overcoming":[337],"receptor":[348],"[abstract].":[352],"In:":[353],"Proceedings":[354],"American":[357],"Association":[358],"Cancer":[360,374],"Research":[361],"Annual":[362],"Meeting":[363],"2019;":[364],"2019":[365],"Mar":[366],"29-Apr":[367],"3;":[368],"Atlanta,":[369],"GA.":[370],"Philadelphia":[371],"(PA):":[372],"AACR;":[373],"Res":[375],"2019;79(13":[376],"Suppl):Abstract":[377],"nr":[378],"3812.":[379]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-05-11T00:00:00"}